Measles vaccines: WHO position paper

Language
Published
2017
Tags

This position paper incorporates the most recent developments in the field of measles and includes removal of introduction criteria for the routine second dose of measles-containing vaccine (MCV2), guidance on when to vaccinate infants from 6 months of age, and guidance on re-vaccination of HIV-infected children receiving highly active anti-retroviral therapy (HAART). It replaces the 2009 WHO position paper on measles vaccines.